Oxalic Acid

Oxalic Acid

SCHEMBL3966802

NC(=O)CN1C[C@@H](CCN2CCN(c3cc(F)c4[nH]ccc4c3)CC2)c2ccccc21.O=C(O)C(=O)O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 2/20 0.36
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
SLC6A2 P23975 1/20 0.36
SLC6A3 Q01959 1/20 0.36
DRD2 P14416 3/20 0.35
HTR1A P08908 2/20 0.35
HTR2A P28223 1/20 0.35
DRD4 P21917 4/20 0.35
DRD3 P35462 3/20 0.34
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
CHRM4 P08173 1/20 0.33
HTR1D P28221 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL3966808 1.00 KDM4E (0.37) KDM4EALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL3953411 0.98 KDM4E (0.38) KDM4EALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL3953405 0.98 KDM4E (0.38) KDM4EALDH1A1MAPTSMN1; SMN2HSD17B10
Oxalic Acid SCHEMBL3961681 0.86 HTR7 (0.44) KDM4EALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL3956617 0.83 HTR7 (0.45) KDM4EALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL3956623 0.83 HTR7 (0.45) KDM4EALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL3964456 0.83 HTR7 (0.45) KDM4EALDH1A1MAPTSMN1; SMN2HSD17B10
Hydrochloric Acid SCHEMBL3965460 0.83 HTR7 (0.45) KDM4EALDH1A1MAPTSMN1; SMN2HSD17B10
Hydrochloric Acid SCHEMBL3960355 0.83 HTR7 (0.45) KDM4EALDH1A1MAPTSMN1; SMN2HSD17B10
Hydrochloric Acid SCHEMBL3960359 0.83 HTR7 (0.45) KDM4EALDH1A1MAPTSMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544685-B2 2,3-dihydroindole compounds H. LUNDBECK A/S (DK) 2009-06-09 US disclosed
EP-1928860-A1 NOVEL 2,3-DIHYDROINDOLE COMPOUNDS H.Lundbeck A/S (DK) 2008-06-11 EP disclosed
WO-2007019867-A1 NOVEL 2,3-DIHYDROINDOLE COMPOUNDS H. LUNDBECK A/S (DK) 2007-02-22 WO disclosed
US-20070043058-A1 Novel 2,3-dihydroindole compounds H. LUNDBECK A/S (DK) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043058-A1 Novel 2,3-dihydroindole compounds HTR2C, HTR2A, HTR5A SLC6A4 28/4885KDM4E 2373/4885ALDH1A1 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.